Somatorelin (1-44) amide (human) (trifluoroacetate salt)
| Code | Size | Price |
|---|
| TAR-T36377-1mg | 1mg | £542.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Somatorelin (1-44) amide is a synthetic peptide that corresponds to the full 44-amino acid sequence of growth hormone-releasing hormone (GHRH), a hormone that stimulates the production of growth hormone from the pituitary gland and is involved in the regulation of cell proliferation and differentiation.1,2Somatorelin induces growth hormone release similarly to GHRHin vitroandin vivo.1
CAS:
0
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Kiaris, H., Chatzistamou, I., Papavassiliou, A.G., et al.Growth hormone-releasing hormone: Not only a neurohormoneTrends Endocrinol. Metab.22(8)311-317(2011)
Guillemin, R., Brazeau, P., B?hlen, P., et al.Growth hormone-releasing factor from a human pancreatic tumor that caused acromegalyScience218(4572)585-587(1982)